Evaluating the Clinical Effectiveness of "Endotracheal Tube Position Anomaly Alerting System"

Condition(s) studied

Investigational drug(s) / intervention(s)

"Endotracheal Tube Position Anomaly Alerting System": The "Endotracheal Tube Position Anomaly Alerting System" (ETPAAS) is designed to assist healthcare providers in managing patients receiving mechanical ventilation via an endotracheal tube. This system integrates an artificial intelligence (AI) algorithm that automatically evaluates the appropriateness of endotracheal tube positioning whenever a patient's chest X-ray is uploaded. If the system detects that the distance between the endotracheal tube tip and the carina falls outside the optimal range, it promptly alerts healthcare providers, enabling timely intervention to correct the tube position and enhance patient safety.

Study summary

The goal of this clinical trial is to determine whether the Endotracheal Tube Position Anomaly Alerting System (ETPAAS) effectively reduces the duration of endotracheal tube malposition in patients admitted to the intensive care unit (ICU). Additionally, the study will assess the clinical impact, usability, and user satisfaction of ETPAAS.

The main questions it aims to answer are:

* Does ETPAAS reduce the duration of endotracheal tube malposition?
* What are healthcare workers' perspectives on the usability and satisfaction of ETPAAS?

Participants will receive standard care, with or without ETPAAS, in the intensive care unit.

Researchers will evaluate the duration of endotracheal tube malposition. Healthcare workers will complete a questionnaire assessing the usability and satisfaction of ETPAAS.

Eligibility

Primary outcome measure(s)

• Duration of endotracheal tube malposition — from the initial detection of endotracheal tube malposition to its correction, an estimated average of 48 hours

Trial sites (1)

More Kaohsiung Medical University Chung-Ho Memorial Hospital trials in Taiwan

Other trials for the same condition